|
[1]WANG YH, YANG W, GERSHWIN ME, et al.Cellular mechanism of immunopathogenesis of primary biliary cirrhosis[J].J Clin Hepatol, 2011, 27 (6) :584-587. (in Chinese) 王寅虎, 杨微, GERSHWIN ME, 等.原发性胆汁性肝硬化的细胞免疫学发病机制[J].临床肝胆病杂志, 2011, 27 (6) :584-587.
|
|
[2]HIRSCHFIELD GM.Diagnosis of primary biliary cirrhosis[J].Best Pract Res Clin Gastroenterol, 2011, 25 (6) :701-712.
|
|
[3]HU CJ, ZHANG FC, LI YZ, et al.Primary biliary cirrhosis:What do autoantibodies tell us?[J].World J Gastroenterol, 2010, 16 (29) :3616-3629.
|
|
[4] GRANITO A, MURATORI P, QUARNETI C, et al.Antinuclear antibodies as ancillary markers in primary biliary cirrhosis[J].Expert Rev Mol Diagn, 2012, 12 (1) :65-74.
|
|
[5]RUFFATTI A, ARSLAN P, FLOREANI A, et al.Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis[J].J Clin Immunol, 1985, 5 (5) :357-361.
|
|
[6]COURVALIN JC, LASSOUED K, BARTNIK E, et al.The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore[J].J Clin Invest, 1990, 86 (1) :279-285.
|
|
[7]NICKOWITZ RE, WOZNIAK RW, SCHAFFNER F, et al.Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis[J].Gastroenterology, 1994, 106 (1) :193-199.
|
|
[8]BANDIN O, COURVALIN JC, POUPON R, et al.Specificity and sensitivity of gp210 autoantibodies detected using an enzymelinked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis[J].Hepatology, 1996, 23 (5) :1020-1024.
|
|
[9]BAUER A, HABIOR A.Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis[J].J Clin Lab Anal, 2007, 21 (4) :227-231.
|
|
[10]MILKIEWICZ P, BUWANESWARAN H, COLTESCU C, et al.Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease[J].Clin Gastroenterol Hepatol, 2009, 7 (12) :1355-1360.
|
|
[11]XIAO H, CHEN JW, XIE X, et al.Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis[J].J Peking Univ:Health Sci, 2012, 44 (2) :209-214. (in Chinese) 肖华, 陈进伟, 谢希, 等.自身抗体检测在原发性胆汁性肝硬化诊断中的价值[J].北京大学学报:医学版, 2012, 44 (2) :209-214.
|
|
[12]GSTSELIS NK, ZACHOU K, NORMAN GL, et al.Clinical significance of the fluctuation of primary biliary cirrhosis-related autoantibodies during the course of the disease[J].Autoimmunity, 2013.
|
|
[13]WU J, ZENG KQ, WANG MJ, et al.Diagnostic value of gp210 and sp100 antibodies in patients with primary biliary cirrhosis[J].China J Modern Med, 2012, 22 (34) :55-57. (in Chinese) 武剑, 曾克勤, 王鸣军, 等.抗gp210、Sp100抗体对原发性胆汁性肝硬化的诊断意义[J].中国现代医学杂志, 2012, 22 (34) :55-57.
|
|
[14]DU HH, LI QM, ZHOU XZ, et al.Diagnostic value of a variety of autoantibodies detection in patients with primary biliary cirrhosis[J].Chin J Liver Dis:Electron Vers, 2013, 5 (1) :19-23. (in Chinese) 杜慧慧, 李青梅, 周希禛, 等.多种自身抗体联合检测在原发性胆汁性肝硬化中的诊断价值[J].中国肝脏病杂志:电子版, 2013, 5 (1) :19-23.
|
|
[15]NAKAMURA M, TAKII Y, KOMORI A, et al.Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis[J].J Hepatology, 2005, 42 (3) :386-392.
|
|
[16]MURATORI P, MURATORI L, FERRRARI R, et al.Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis[J].Am J Gastroenterol, 2003, 98 (2) :431-437.
|
|
[17]GAO L, TIAN X, LIU B, et al.The value of antinuclear antibodies in primary biliary cirrhosis[J].Clin Exp Med, 2008, 8 (1) :9-15.
|
|
[18]HU CJ, DENG CW, SONG G, et al.Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis[J].Dig Dis Sci, 2011, 56 (11) :3357-3363.
|
|
[19]LIU HH, FU JL, XU J, et al.Clinical manifestation and autoantibody profile in 123 patients with primary biliary cirrhosis[J].J Peking Univ:Health Sci, 2013, 45 (2) :233-237. (in Chinese) 刘红虹, 福军亮, 徐军, 等.123例原发性胆汁性肝硬化临床表现与自身抗体谱[J].北京大学学报:医学版, 2013, 45 (2) :233-237.
|
|
[20]WORMAN HJ, COURVALIN JC.Antinuclear antibodies specific for primary biliary cirrhosis[J].Autoimmunity Reviews, 2003, 2 (4) :211-217.
|
|
[21]ITOH S, ICHIDA T, YOSHIDA T, et al.Autoantibodies against a210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis[J].J Gastroenterol Hepatol, 1998, 13 (3) :257-265.
|
|
[22]ISHIBASHI H, KOMORI A, SHIMODA S, et al.Risk factors of prediction of long-term outcome in primary biliary cirrhosis[J].Intern Med, 2011, 50 (1) :1-10.
|
|
[23]NAKAMURA M, KONDO H, MORI T, et al.Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis[J].Hepatology, 2007, 45 (1) :118-127.
|
|
[24]LIU HH, FU JL, FU BY, et al.The pathogenesis and risk factors related to prognosis of primary biliary cirrhosis[J].J Clin Hepatol, 2012, 28 (2) , 153-155. (in Chinese) 刘红虹, 福军亮, 付宝云, 等.原发性胆汁性肝硬化的发病机制及影响预后的危险因素研究进展[J].临床肝胆病杂志, 2012, 28 (2) :153-155.
|
|
[25]NAKAMURA M, TAKII Y, ITO M, et al.Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis[J].J Autoimmun, 2006, 26 (2) :138-145.
|
DownLoad: